Chemkart India Ltd

Chemkart India Ltd has announced that its Board of Directors will convene on October 30, 2026, to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the Half Year ended September 30, 2026. The trading window for designated persons and their immediate relatives has been closed since September 26, 2026, and will reopen 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Chemkart India Ltd has informed the stock exchange about a change in its Corporate Identification Number (CIN) and listing status. The CIN has been updated from U51220MH2020PLC338631 to L51220MH2020PLC338631, and the listing status has changed from 'No' to 'Yes'. This change reflects the company's equity shares being listed on BSE Limited and updates to its master data with the Ministry of Corporate Affairs (MCA). The company has requested BSE to update its records accordingly.

Chemkart India Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective October 1, 2026. This closure will remain in effect until 48 hours after the declaration of the un-audited standalone and consolidated financial results for the half-year ending September 30, 2026. During this period, trading in the company's equity shares by these individuals is prohibited, in accordance with SEBI's Insider Trading Regulations. The date for the board meeting to approve these financial results will be communicated separately.

Chemkart India Ltd has invested ₹1.30 Crores in its wholly-owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. This investment involves the allotment of 13,00,000 equity shares at face value. The funds are intended for commissioning the subsidiary's manufacturing unit, aligning with the company's IPO objectives. Easy Raw Materials Private Limited is involved in trading pharma products and nutritional supplements. As of March 31, 2026, the subsidiary reported NIL turnover, a loss after tax of ₹59.47 Lakhs, and a net worth of ₹578.60 Lakhs. The transaction is considered a related party transaction but is conducted at arm's length.

Chemkart India Ltd announced the resignation of Mr. Basavaraj Shankar Dalawai as Chief Financial Officer and Key Managerial Personnel, effective September 10, 2026, due to internal restructuring. Concurrently, the Board of Directors, based on recommendations from the Audit and Nomination & Remuneration Committees, has appointed Mr. Mohammad Asim Siddiqui as the new Chief Financial Officer and Whole-Time Key Managerial Personnel, effective September 11, 2026. Mr. Siddiqui has confirmed his eligibility and provided his consent for the role.

Chemkart India Ltd announced the resignation of its Chief Financial Officer, Mr. Basavaraj Shankar Dalawai, effective September 10, 2026, due to internal restructuring. Concurrently, the company appointed Mr. Mohammad Asim Siddiqui as the new Chief Financial Officer, effective September 11, 2026. Both appointments and resignations were approved by the Board of Directors.

Chemkart India Ltd announced a change in its Chief Financial Officer (CFO) role during its Board Meeting on September 10, 2026. Mr. Basavaraj Shankar Dalawai resigned from his position as CFO and Key Managerial Personnel, effective closing business hours of September 10, 2026, due to internal restructuring and transition. The Board accepted his resignation. Subsequently, Mr. Mohammad Asim Siddiqui has been appointed as the new CFO and Whole-Time Key Managerial Personnel, effective September 11, 2026, based on recommendations from the Audit Committee and Nomination and Remuneration Committee.

Chemkart India Ltd has issued a revised Annual Report for the financial year 2025-26, rectifying typographical errors and inadvertent oversights found in the previously submitted document. The updated report is available on the company's website. The report highlights a revenue growth to ₹21,259.48 Lakh from ₹20,327.85 Lakh in the prior year, underscoring the company's resilient business model and customer confidence. Chemkart India aims to expand its product portfolio, strengthen customer relationships, enhance operational efficiencies, and invest in quality systems to capitalize on the growing nutraceutical market.

Chemkart India Ltd has filed its Annual Report for the Financial Year 2025-26. The company announced that its 7th Annual General Meeting (AGM 2026) is scheduled for September 19, 2026, to be held via Video Conferencing. The report highlights a revenue from operations of ₹21,259.48 Lakh for FY 2025-26, an increase from ₹20,327.85 Lakh in the previous year. Key priorities for the year included enhancing operational efficiencies, investing in quality systems, and expanding the product portfolio. The company aims to capitalize on the growing Indian nutraceutical market by focusing on value-added manufacturing and strengthening customer relationships.

Chemkart India Ltd has announced its 7th Annual General Meeting (AGM) will be held on September 19, 2026, at 12:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio Video Means (OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, the reappointment of Mr. Shailesh Vinodrai Mehta as a director, and the appointment of statutory auditors. Shareholders will have the opportunity to participate through remote e-voting, which opens on September 16, 2026, and closes on September 18, 2026. The cut-off date for determining eligible shareholders for e-voting is September 12, 2026. The full notice will be available on the company's website.